Archive for September, 2012

Biomarketing strategy and tactics 101 PART III of III

The American Marketing Association defines marketing as the activity, set of institutions, and processes for creating, communicating, delivering, and exchanging offerings that have value for customers, clients, partners, and society at large. According…


Biomarketing strategy and tactics 101 PART III of III

The American Marketing Association defines marketing as the activity, set of institutions, and processes for creating, communicating, delivering, and exchanging offerings that have value for customers, clients, partners, and society at large. According…


Tipping Point: Biosimilars, Emerging Markets, and Public-Private Engagement to Promote Global Health

Biosimilars, also known as follow on biologics, are complex biotechnology drugs that are similar, but not identical, to original biologic drug forms, and represent potential lower cost versions that may improve access. Yet biologics and their biosimila…


Tipping Point: Biosimilars, Emerging Markets, and Public-Private Engagement to Promote Global Health

Biosimilars, also known as follow on biologics, are complex biotechnology drugs that are similar, but not identical, to original biologic drug forms, and represent potential lower cost versions that may improve access. Yet biologics and their biosimila…


Not fully harmonized: Differences in biotechnology patenting between Europe and the United States

There has been a trend of worldwide harmonization of patent laws. Due to the continuing harmonization, examination of patents in Europe and the United States are very similar.  However, examination standards between the two patent offices can differ. …


Not fully harmonized: Differences in biotechnology patenting between Europe and the United States

There has been a trend of worldwide harmonization of patent laws. Due to the continuing harmonization, examination of patents in Europe and the United States are very similar.  However, examination standards between the two patent offices can differ. …


The Partnership for Safe Medicines-India: Lessons for Emerging Markets

While medicines are always expected to be a safe remedy for human ailments, unfortunately, there is also the phenomenon of ‘unsafe medicines’ due to unscrupulous elements in society manufacturing and marketing fake, spurious, mislabeled medicines, …


The Partnership for Safe Medicines-India: Lessons for Emerging Markets

While medicines are always expected to be a safe remedy for human ailments, unfortunately, there is also the phenomenon of ‘unsafe medicines’ due to unscrupulous elements in society manufacturing and marketing fake, spurious, mislabeled medicines, …